For state Medicaid agencies that opt to participate in the model, implementation will be on a rolling basis from May 1, 2026 through January 1, 2027
Wegovy Pill (Oral Formulation) The Wegovy pill launched in January 2026 as the first FDA-approved oral GLP-1 receptor agonist specifically indicated for chronic weight management
177 A thorough discussion of weight loss strategies is included in the Weight Management protocol
3R4F research grade cigarettes with a regular amount of nicotine were used in this study (KTRDC Tobacco Biotechnology Group, University of Kentucky, Lexington, KY, USA)
You see, as your body adapts to your differing calorie intake, it also adapts to repetitive workouts, which means you burn fewer calories over time and that can stall your weight loss